PT  - JOURNAL ARTICLE
AU  - Thampi, Nisha
AU  - Burhunduli, Tasha
AU  - Strain, Jamie
AU  - Raudanskis, Ashley
AU  - Moggridge, Jason A.
AU  - Hinz, Aaron
AU  - Doukhanine, Evgueni
AU  - Castellani,
AU  - Fralick,
AU  - Kassen, Rees
AU  - McCready, Janine
AU  - Nott, Caroline
AU  - Wong,
AU  - MacFadden, Derek R.
TI  - Detection of SARS-CoV-2 in Schools Using Built Environment Testing in Ottawa, Canada: A Multi-Facility Prospective Surveillance Study
AID  - 10.1101/2023.03.03.23286750
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.03.23286750
4099  - http://medrxiv.org/content/early/2023/03/10/2023.03.03.23286750.short
4100  - http://medrxiv.org/content/early/2023/03/10/2023.03.03.23286750.full
AB  - Classroom and staffroom floor swabs across six elementary schools in Ottawa, Canada were tested for SARS-CoV-2. Schools in neighbourhoods with historically elevated COVID-19 burden had lower environmental swab positivity. Environmental test positivity did not correlate with student grade groups, school-level absenteeism, pediatric COVID-19-related hospitalizations, or community SARS-CoV-2 wastewater levels.Summary Environmental SARS-CoV-2 sampling was performed in six schools in Ottawa, Canada. The percentage of floor swabs detecting SARS-CoV2 was not correlated with absenteeism, pediatric hospitalizations, or wastewater data. Schools in neighbourhoods with previously elevated COVID-19 rates had lower test positivity.Competing Interest StatementED works for DNA Genotek that provided sampling swabs in-kind for this study in an unrestricted fashion. DNA Genotek had no control over the findings, interpretations, or conclusions published in this paper. MF is a consultant for ProofDx, a start-up company that has created a point of care testing device for adults with COVID-19 using CRISPR. DM is a consultant for wastewater surveillance, World Bank. All other authors have no relevant conflicts to disclose.Funding StatementThis project was supported by funding from a CIHR Operating Grant (EGA 179419).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics review was waived by the Research Ethics Board of the University of Ottawa as no identifiable human data were collected.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data is not available for sharing.